share_log

Health Check: How Prudently Does China Reform Health Management and Services Group (SZSE:000503) Use Debt?

Health Check: How Prudently Does China Reform Health Management and Services Group (SZSE:000503) Use Debt?

健康檢查:中國如何謹慎地改革健康管理與服務集團(SZSE: 000503)使用債務?
Simply Wall St ·  2023/11/23 17:49

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. We note that China Reform Health Management and Services Group Co., Ltd. (SZSE:000503) does have debt on its balance sheet. But the real question is whether this debt is making the company risky.

由伯克希爾·哈撒韋公司的查理·芒格支持的外部基金經理李璐對此毫不掩飾,他說:“最大的投資風險不是價格的波動,而是你是否會遭受永久性的資本損失。”因此,很明顯,當你考慮任何給定股票的風險時,你需要考慮債務,因爲過多的債務會使公司陷入困境。我們注意到,中改健康管理服務集團有限公司(SZSE:000503)的資產負債表上確實有債務。但真正的問題是,這筆債務是否使公司面臨風險。

When Is Debt A Problem?

債務何時會成爲問題?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we examine debt levels, we first consider both cash and debt levels, together.

一般而言,只有當公司無法通過籌集資金或用自己的現金流輕鬆還清債務時,債務才會成爲真正的問題。如果情況變得非常糟糕,貸款人可以控制業務。但是,更頻繁(但仍然代價高昂)的情況是,公司必須以低廉的價格發行股票,永久稀釋股東,以支撐其資產負債表。但是,通過取代稀釋,對於需要資金以高回報率投資增長的企業來說,債務可能是一個非常好的工具。當我們研究債務水平時,我們首先要同時考慮現金和債務水平。

See our latest analysis for China Reform Health Management and Services Group

查看我們對中國改革健康管理與服務集團的最新分析

What Is China Reform Health Management and Services Group's Net Debt?

中國改革健康管理與服務集團的淨負債是多少?

You can click the graphic below for the historical numbers, but it shows that as of September 2023 China Reform Health Management and Services Group had CN¥180.2m of debt, an increase on CN¥40.0m, over one year. But on the other hand it also has CN¥511.4m in cash, leading to a CN¥331.2m net cash position.

你可以點擊下圖查看歷史數字,但它顯示,截至2023年9月,中國改革健康管理與服務集團在一年內有1.802億元人民幣的債務,比4000萬元人民幣增加了人民幣。但另一方面,它也有5.114億元人民幣的現金,淨現金頭寸爲3.312億元人民幣。

debt-equity-history-analysis
SZSE:000503 Debt to Equity History November 23rd 2023
深交所:000503 債權與股權歷史記錄 2023 年 11 月 23 日

A Look At China Reform Health Management and Services Group's Liabilities

看看中國改革健康管理與服務集團的負債

We can see from the most recent balance sheet that China Reform Health Management and Services Group had liabilities of CN¥443.1m falling due within a year, and liabilities of CN¥2.18m due beyond that. Offsetting these obligations, it had cash of CN¥511.4m as well as receivables valued at CN¥184.7m due within 12 months. So it can boast CN¥250.8m more liquid assets than total liabilities.

我們可以從最新的資產負債表中看出,中改健康管理與服務集團在一年內到期的負債爲4.431億元人民幣,此後到期的負債爲218萬元人民幣。爲了抵消這些債務,它有5.114億元人民幣的現金以及價值1.847億元人民幣的應收賬款,將在12個月內到期。因此,它的流動性資產可以比之多2.508億元人民幣 負債。

This state of affairs indicates that China Reform Health Management and Services Group's balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets. So while it's hard to imagine that the CN¥13.1b company is struggling for cash, we still think it's worth monitoring its balance sheet. Simply put, the fact that China Reform Health Management and Services Group has more cash than debt is arguably a good indication that it can manage its debt safely. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since China Reform Health Management and Services Group will need earnings to service that debt. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

這種狀況表明,中改健康管理與服務集團的資產負債表看起來相當穩健,因爲其總負債幾乎等於其流動資產。因此,儘管很難想象這家價值131億元人民幣的公司正在爲現金而苦苦掙扎,但我們仍然認爲值得監控其資產負債表。簡而言之,中國改革健康管理與服務集團的現金多於債務這一事實可以說很好地表明它可以安全地管理債務。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但是你不能完全孤立地看待債務;因爲中國改革醫療管理與服務集團需要收益來償還這筆債務。因此,如果你想進一步了解其收益,可能值得看看這張長期收益趨勢圖。

In the last year China Reform Health Management and Services Group wasn't profitable at an EBIT level, but managed to grow its revenue by 18%, to CN¥337m. We usually like to see faster growth from unprofitable companies, but each to their own.

去年,中國改革健康管理與服務集團在息稅前利潤水平上沒有實現盈利,但設法將其收入增長了18%,達到3.37億元人民幣。我們通常希望看到無利可圖的公司實現更快的增長,但每家公司都有自己的增長。

So How Risky Is China Reform Health Management and Services Group?

那麼,中國改革健康管理與服務集團的風險有多大?

We have no doubt that loss making companies are, in general, riskier than profitable ones. And we do note that China Reform Health Management and Services Group had an earnings before interest and tax (EBIT) loss, over the last year. And over the same period it saw negative free cash outflow of CN¥170m and booked a CN¥77m accounting loss. Given it only has net cash of CN¥331.2m, the company may need to raise more capital if it doesn't reach break-even soon. Overall, its balance sheet doesn't seem overly risky, at the moment, but we're always cautious until we see the positive free cash flow. When we look at a riskier company, we like to check how their profits (or losses) are trending over time. Today, we're providing readers this interactive graph showing how China Reform Health Management and Services Group's profit, revenue, and operating cashflow have changed over the last few years.

我們毫不懷疑,總體而言,虧損公司比盈利公司的風險更大。我們確實注意到,中國改革健康管理與服務集團去年出現利息稅前收益(EBIT)虧損。同期,它的自由現金流出爲負1.7億元人民幣,會計虧損爲7700萬元人民幣。鑑於該公司只有3.312億元人民幣的淨現金,如果不能很快達到收支平衡,則可能需要籌集更多資金。總體而言,目前其資產負債表似乎風險不大,但在看到正的自由現金流之前,我們始終保持謹慎。當我們看一家風險較高的公司時,我們想看看他們的利潤(或虧損)在一段時間內的趨勢。今天,我們爲讀者提供這張互動圖表,顯示了中國改革健康管理與服務集團在過去幾年中的利潤、收入和運營現金流發生了怎樣的變化。

At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.

歸根結底,通常最好將注意力集中在沒有淨負債的公司身上。您可以訪問我們的此類公司的特別名單(所有公司都有利潤增長記錄)。它是免費的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論